DEveloping Tests for Endometrial Cancer deTection (DETECT): protocol for a diagnostic accuracy study of urine and vaginal samples for the detection of endometrial cancer by cytology in women with postmenopausal bleeding

被引:10
|
作者
Jones, Eleanor R. [1 ,2 ]
Carter, Suzanne [1 ]
O'Flynn, Helena [1 ]
Njoku, Kelechi [1 ]
Barr, Chloe E. [1 ,2 ]
Narine, Nadira [3 ]
Shelton, David [3 ]
Rana, Durgesh [3 ]
Crosbie, Emma J. [1 ,2 ]
机构
[1] Univ Manchester, Div Canc Sci, Manchester, Lancs, England
[2] Manchester Univ NHS Fdn Trust, Dept Obstet & Gynaecol, Manchester, Lancs, England
[3] Manchester Univ NHS Fdn Trust, Manchester Cytol Ctr, Manchester, Lancs, England
来源
BMJ OPEN | 2021年 / 11卷 / 07期
基金
英国惠康基金; 美国国家卫生研究院;
关键词
gynaecological oncology; cytopathology; primary care;
D O I
10.1136/bmjopen-2021-050755
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Postmenopausal bleeding (PMB), the red flag symptom for endometrial cancer, triggers urgent investigation by transvaginal ultrasound scan, hysteroscopy and/or endometrial biopsy. These investigations are costly, invasive and often painful or distressing for women. In a pilot study, we found that voided urine and non-invasive vaginal samples from women with endometrial cancer contain malignant cells that can be identified by cytology. The aim of the DEveloping Tests for Endometrial Cancer deTection (DETECT) Study is to determine the diagnostic test accuracy of urine and vaginal cytology for endometrial cancer detection in women with PMB. Methods and analysis This is a multicentre diagnostic accuracy study of women referred to secondary care with PMB. Eligible women will be asked to provide a self-collected voided urine sample and a vaginal sample collected with a Delphi screener before routine clinical procedures. Pairs of specialist cytologists, blinded to participant cancer status, will assess and classify samples independently, with differences settled by consensus review or involving a third cytologist. Results will be compared with clinical outcomes from standard diagnostic tests. A sample size of 2000 women will have 80% power to establish a sensitivity of vaginal samples for endometrial cancer detection by cytology of >= 85%+/- 7%, assuming 5% endometrial cancer prevalence. The primary objective is to determine the diagnostic accuracy of urogenital samples for endometrial cancer detection by cytology. Secondary objectives include the acceptability of urine and vaginal sampling to women. Ethics and dissemination This study has been approved by the North West-Greater Manchester West Research Ethics Committee (16/NW/0660) and the Health Research Authority. Results will be disseminated through publication in peer-reviewed scientific journals, presentation at conferences and via charity websites.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Diagnostic accuracy of cytology for the detection of endometrial cancer in urine and vaginal samples
    Helena O’Flynn
    Neil A. J. Ryan
    Nadira Narine
    David Shelton
    Durgesh Rana
    Emma J. Crosbie
    Nature Communications, 12
  • [2] Diagnostic accuracy of cytology for the detection of endometrial cancer in urine and vaginal samples
    O'Flynn, Helena
    Ryan, Neil A. J.
    Narine, Nadira
    Shelton, David
    Rana, Durgesh
    Crosbie, Emma J.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [3] Urine and vaginal cytology for endometrial cancer detection in symptomatic women
    Jones, Eleanor
    Narine, Nadira
    O'Flynn, Helena
    Barr, Chloe
    Njoku, Kelechi
    Carter, Suzanne
    Cornwall, Lisa
    Vinay, Sylvia
    Fullwood, Catherine
    Shelton, David
    Rana, Durgesh
    Crosbie, Emma
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 : 39 - 40
  • [4] DIAGNOSTIC ACCURACY OF LIQUID-BASED ENDOMETRIAL CYTOLOGY IN ENDOMETRIAL CANCER DETECTION
    Sorbi, F.
    Fambrini, M.
    Sisti, G.
    Pieralli, A.
    Guaschino, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [5] Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding
    Tabor, A
    Watt, HC
    Wald, NJ
    OBSTETRICS AND GYNECOLOGY, 2002, 99 (04): : 663 - 670
  • [6] Opportunities for Early Detection of Endometrial Cancer in Women With Postmenopausal Bleeding
    Matteson, Kristen A.
    Robison, Katina
    Jacoby, Vanessa L.
    JAMA INTERNAL MEDICINE, 2018, 178 (09) : 1222 - 1223
  • [7] Reappraisal of endometrial thickness for the detection of endometrial cancer in postmenopausal bleeding: a retrospective cohort study
    Wong, A. S-W
    Lao, T. T-H
    Cheung, C. W.
    Yeung, S. W.
    Fan, H. L.
    Ng, P. S.
    Yuen, P. M.
    Sahota, D. S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 123 (03) : 439 - 446
  • [8] DETECTION OF ENDOMETRIAL CANCER IN POSTMENOPAUSAL WOMEN - REPLY
    BOURNE, TH
    CAMPBELL, S
    COLLINS, WP
    BRITISH MEDICAL JOURNAL, 1990, 301 (6756): : 874 - 874
  • [9] VAGINOSONOGRAPHIC DETECTION OF ENDOMETRIAL CANCER IN POSTMENOPAUSAL WOMEN
    OSMERS, R
    VOLKSEN, M
    RATH, W
    KUHN, W
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1990, 32 (01) : 35 - 37
  • [10] Re: Reappraisal of endometrial thickness for the detection of endometrial cancer in postmenopausal bleeding: a retrospective cohort study
    Cheung, V. Y. T.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 123 (03) : 478 - 479